Oliver J. McElvaney

University of Washington — United States

Medicine · Health Sciences

23h-index2.6kcitations88works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(34), Protease and Inhibitor Mechanisms(24), Neonatal Respiratory Health Research(18), Peptidase Inhibition and Analysis(16), Respiratory Support and Mechanisms(8)

Publications88 total

A state of the union on alpha-1 antitrypsin deficiency at the Veterans Health Administration
Annals of the American Thoracic Society·2026
Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes
Journal of Cystic Fibrosis·2025Open Access
366 Predictive biomarkers for long-term chronic kidney disease in adults with cystic fibrosis
Journal of Cystic Fibrosis·2025
An alternative view of changes in lung function among people with cystic fibrosis
Journal of Cystic Fibrosis·2025
Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US
Journal of Cystic Fibrosis·2025Open Access
Further Insights into Emphysema Progression and Lung Function Decline in MZ Alpha-1 Antitrypsin Deficiency
Annals of the American Thoracic Society·2025Open Access
EPS7.04Real world evaluation of the CF-ABLE score as a prognostic tool and clinical endpoint in cystic fibrosis
Journal of Cystic Fibrosis·2025
WS15.01Post-lung transplant survival for people with cystic fibrosis before and during the elexacaftor/tezacaftor/ivacaftor era
Journal of Cystic Fibrosis·2025
WS07.06Early change in forced vital capacity as a determinant of outcome in pulmonary exacerbations of cystic fibrosis
Journal of Cystic Fibrosis·2025
Alpha-1 Antitrypsin – A Prognostic Factor in Acute Respiratory Distress Syndrome
American Journal of Respiratory and Critical Care Medicine·2025
Initial Characterization of the Alpha-1 Biomarker Consortium
American Journal of Respiratory and Critical Care Medicine·2025
Rationale and Design of the Alpha-1 Biomarkers Consortium Study
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·2025Open Access
862 Use of elexacaftor/tezacaftor/ivacaftor in lung transplant recipients with cystic fibrosis in the United States: a CFF Patient Registry Analysis
Journal of Cystic Fibrosis·2024
Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators
BMC Pulmonary Medicine·2024· 4 citedOpen Access
International Medical Graduates and the Physician Workforce
JAMA·2024· 28 cited
Clinical Trial Participation in Cystic Fibrosis Assessed by Race and Ethnicity
2024
Barriers and Facilitators to Discussing Lung Transplantation Among Individuals With Cystic Fibrosis in the Era of Highly Effective Modulators
2024
Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis
Annals of the American Thoracic Society·2023· 17 citedOpen Access
Undiagnosed Alpha-1 Antitrypsin Deficiency and the Perpetuation of Lung Health Inequity
American Journal of Respiratory and Critical Care Medicine·2023· 4 citedOpen Access
Using Registries and Databases to Drive up Quality
2023
page 1 of 5Next →

Frequent Co-authors

Noel G. McElvaney(43), Emer P. Reeves(25), Oisín F. McElvaney(17), Cedric Gunaratnam(16), Tomás P. Carroll(15), Mark P. Murphy(13), Jennifer Clarke(9), Gerard F. Curley(9), Natalie McEvoy(8), David A. Bergin(7), Paula Meleady(7), Michael Henry(7), Cormac McCarthy(7), Kerstin Pohl(6), D. Fraughen(6), Eoin O’Connor(5), Grace Hogan(5), Brian D. Hobbs(5), Karen McQuillan(5), Christopher H. Goss(5)